Hepatitis A virus, inactivated · Hepatitis A
Health Canada DIN 02237792. Check the product and formulation on your record before using a schedule.
Plan doses for this product →Two doses, 6 or more months apart.
AVAXIM is listed under Health Canada DIN 02237792. The product record and monograph below describe this formulation; the dose schedule comes from the Canadian Immunization Guide.
02237792Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with a healthcare professional.
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
A listed product may not be stocked or publicly funded.
These steps come from the Canadian Immunization Guide's administration practices and acute reactions guidance.
For product-specific effects and precautions, check this DIN in the Health Canada product record and monograph. The general appointment steps above apply to all vaccinations.
No directly matching Pharmasist product guide was identified for this DIN. Use the linked Health Canada record to check your exact product.
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination. Public health recommendations may differ from a product monograph's authorized schedule.
Two doses of hepatitis A vaccine, the second 6 to 36 months after the first depending on the product.
Adult products: HAVRIX 1440 for 19 years and older (dose 2 at 6 to 12 months), AVAXIM for 12 years and older (dose 2 at 6 to 36 months), VAQTA adult for 18 years and older (dose 2 at 6 to 18 months). One dose gives protective antibody in nearly all recipients; the second gives long-term protection.
Standard two-dose hepatitis A series; the response may be reduced.
Hepatitis A vaccine may be given to immunocompromised people; the response may be reduced but the vaccine still offers some protection. Immune globulin may be considered for pre- and post-exposure protection, and blood testing after immunization may be considered where available.
Family guidance on pregnancy: Use if indicated: after an exposure, or for travel to an endemic area.
Family guidance on breastfeeding: Use if indicated.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
General information only. A suggested date is not an appointment or a prescription; a healthcare professional confirms what you need. Clinical rules reviewed on 2026-09-27.
Explore care options